University of Birmingham researchers have received a £1.8M grant by the NIHR EME Programme investigating BCG vaccine efficacy in reducing COPD exacerbations.
‘Resistance breakers’ and better genetic tests are among new ways that scientists could address antimicrobial resistance, a new paper suggests.
Lessons from the genetic mutations which led to Covid-19 variants such as Alpha and Omicron could help scientists tackle similar changes in Monkeypox.
Renewed National Institute for Health and Care Research Birmingham Biomedical Research Centre continue funds for developments around inflammatory diseases
A carbohydrate commonly found attached to plant proteins is a food source for the bacteria in our gut, new research suggests.
The researchers identified synthetic polymers that induce biofilm formation in E. coli, a bacterium commonly used in biocatalysis.
Researchers have developed new antimicrobial technology for air filters that can kill bacteria, fungi and viruses including SARS-CoV-2.
Young men exposed to parasitic roundworm may be at increased risk of developing asthma and serious lung damage, a new study reveals.
A UK-wide trial carried out in collaboration with the University of Birmingham show six COVID-19 vaccines are safe and boost immunity for people who have had two doses of Pfizer/BioNTech or Oxford/AstraZeneca.
Professor Willem van Schaik, Director of the Institute of Microbiology and Infection, writes an opinion piece on how the dynamics of infectious diseases will change on a warming planet.
New research has found that the use of non-invasive breathing support to treat patients with moderate to severe COVID-19 in hospitals isn't linked to a heightened risk of transmitting infection to others.
Construction of No.1 Birmingham Health Innovation Campus (BHIC) in Selly Oak is underway, marking a major milestone for the region's rapidly growing life sciences sector.